Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Cytek BioSciences Inc (NASDAQ: CTKB) closed at $4.14 down -0.72% from its previous closing price of $4.17. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 0.84 million shares were traded. CTKB stock price reached its highest trading level at $4.205 during the session, while it also had its lowest trading level at $4.05.
Ratios:
For a deeper understanding of Cytek BioSciences Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.27. For the most recent quarter (mrq), Quick Ratio is recorded 5.21 and its Current Ratio is at 5.86. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 31, 2025, Downgraded its rating to Sell and sets its target price to $4.50 from $7 previously.
On December 14, 2023, Stephens started tracking the stock assigning a Overweight rating and target price of $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 19 ’24 when Yan Ming sold 20,000 shares for $5.87 per share. The transaction valued at 117,400 led to the insider holds 5,988,502 shares of the business.
Yan Ming sold 1,900 shares of CTKB for $13,304 on Apr 09 ’24. The CHIEF TECHNOLOGY OFFICER now owns 6,008,502 shares after completing the transaction at $7.00 per share. On Mar 18 ’24, another insider, Yan Ming, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 20,000 shares for $6.77 each. As a result, the insider received 135,400 and left with 6,030,402 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTKB now has a Market Capitalization of 530321568 and an Enterprise Value of 269478144. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65 while its Price-to-Book (P/B) ratio in mrq is 1.35. Its current Enterprise Value per Revenue stands at 1.344 whereas that against EBITDA is -16.937.
Stock Price History:
The Beta on a monthly basis for CTKB is 1.39, which has changed by -0.40431654 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, CTKB has reached a high of $7.63, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -24.51%, while the 200-Day Moving Average is calculated to be -27.56%.
Shares Statistics:
For the past three months, CTKB has traded an average of 760.41K shares per day and 866560 over the past ten days. A total of 129.21M shares are outstanding, with a floating share count of 116.15M. Insiders hold about 9.33% of the company’s shares, while institutions hold 60.14% stake in the company. Shares short for CTKB as of 1740700800 were 3450615 with a Short Ratio of 4.54, compared to 1738281600 on 3173072. Therefore, it implies a Short% of Shares Outstanding of 3450615 and a Short% of Float of 3.4799999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
